Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bouloux

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Human Molecular Genetics|April 1, 1993
Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndromeJ P Hardelin, J Levilliers, S Blanchard, et al.
Psychoneuroendocrinology|January 1, 1990
Endogenous opioids modulate the cardiovascular response to mental stressM Morris, P Salmon, H Steinberg, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.
The New England Journal of Medicine|July 27, 1989
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11R V Thakker, P Bouloux, C Wooding, et al.
Journal of Medical Genetics|October 1, 1993
Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinismA Meindl, D Hosenfeld, W Brückl, et al.
Clinical Science (London, England : 1979)|November 1, 1984
The role of opioid peptides in the hormonal responses to acute exercise in manA Grossman, P Bouloux, P Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1992
X chromosome-linked Kallmann syndrome: stop mutations validate the candidate geneJ P Hardelin, J Levilliers, I del Castillo, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 26, 2013
The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young menC P Velloso, M Aperghis, R Godfrey, et al.
Annals of Human Genetics|January 1, 1993
Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 familiesR V Thakker, C Wooding, J T Pang, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Human Molecular Genetics|April 1, 1993
Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndromeJ P Hardelin, J Levilliers, S Blanchard, et al.
Psychoneuroendocrinology|January 1, 1990
Endogenous opioids modulate the cardiovascular response to mental stressM Morris, P Salmon, H Steinberg, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.
The New England Journal of Medicine|July 27, 1989
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11R V Thakker, P Bouloux, C Wooding, et al.
Journal of Medical Genetics|October 1, 1993
Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinismA Meindl, D Hosenfeld, W Brückl, et al.
Clinical Science (London, England : 1979)|November 1, 1984
The role of opioid peptides in the hormonal responses to acute exercise in manA Grossman, P Bouloux, P Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1992
X chromosome-linked Kallmann syndrome: stop mutations validate the candidate geneJ P Hardelin, J Levilliers, I del Castillo, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 26, 2013
The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young menC P Velloso, M Aperghis, R Godfrey, et al.
Annals of Human Genetics|January 1, 1993
Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 familiesR V Thakker, C Wooding, J T Pang, et al.
Pageof 3